Table 1.
Patients with Fabry disease: comparison of patients with cTnI elevation ≥0.04 ng/ml versus without.
Table 2.
Multiple logistic regression analysis for elevated cardiac troponin (cut-off ≥0.04 ng/ml) patients with Fabry disease (n = 62).
Table 3.
Patients with Fabry disease dichotomized according to different categories of cTnI levels.
Table 4.
Characteristics in 17 age- and sex-matched individuals with left ventricular hypertrophy due to hypertension.
Fig 1.
Comparison of cardiac troponin I levels.
Presented are patients with Fabry disease (FD) and left ventricular hypertrophy (LVH) (n = 17) versus FD patients without LVH (n = 18) and non-FD patients with LVH of other cause (n = 17). The cut-off level for cTnI in diagnosing myocardial infarction (≥0.04 ng/ml) is indicated in the figure.